SucralfateThird Party Manufacturing in India

Sucralfate works by selectively coating and protecting ulcerated areas in the gastrointestinal tract to promote natural mucosal healing.

When exposed to stomach acid, Sucralfate dissociates into aluminum and sucrose sulfate ions, quickly cross-linking to form a viscous, gel-like substance. This strong physical barrier firmly adheres to the exposed proteins at the site of ulcers and erosions, actively shielding the lesions from gastric acid, pepsin, and bile salts.

Unlike systemic proton pump inhibitors or H2 blockers, Sucralfate acts locally without significantly altering the stomach's pH or being absorbed into the bloodstream. It is well-tolerated and highly effective for patients requiring mucosal protection during active ulcer flares.

Therapeutic Uses

Sucralfate is prescribed for the treatment of:

• Duodenal and Gastric Ulcers: Provides a protective coating to accelerate the healing of active ulcers.
• Stress Ulcer Prophylaxis: Prevents the formation of stress-induced bleeding in critically ill patients.
• Gastroesophageal Reflux Disease (GERD): Alleviates symptoms of acid reflux by protecting the damaged esophageal mucosa.
• Radiation Proctitis: Used topically or as an enema to treat inflammation caused by pelvic radiation therapy.

Why Manufacturers Choose Sucralfate

Sucralfate is a staple in the gastroenterology portfolio because of its unique, localized mechanism of action and excellent safety profile. Its lack of systemic absorption makes it safe for long-term use and for pregnant patients, maintaining high demand in both domestic and international markets.

This makes Sucralfate one of the most sought-after cytoprotective agents for third party manufacturing in India, with consistent demand from PCD franchise operators, hospitals, and export-oriented companies.